To corroborate these encouraging in vitro results, xenografts with p16-deficient mesothelioma cell line H2373 provided in vivo proof that induction of TAT-p16 decreases CDK4\6 activity resulting in hypophosphorylation of RB1 [8]. This evidence concerns the gene CDKN2A and mesothelioma.